electroCore, Inc. (ECOR) CEO Dan Goldberger on Q2 2021 Results - Earnings Call TranscriptSeeking Alpha • 08/08/21
ElectroCore Stock Is Trading Higher As Ladenburg Initiates Coverage With $3 Price Target, Buy RatingBenzinga • 07/27/21
electroCore Announces Issuance of New Patent for Migraine Treatment using SmartphonesGlobeNewsWire • 07/27/21
electroCore announces Dr. Peter Staats to receive Lifetime Achievement Award from the American Society of Pain and NeuroscienceGlobeNewsWire • 07/19/21
electroCore to Participate in the Ladenburg Thalmann 2021 Virtual Healthcare ConferenceGlobeNewsWire • 07/09/21
electroCore Announces Pricing of $18.0 Million Public Offering of Common StockGlobeNewsWire • 06/30/21
electroCore Announces Publication of Study on the Effect of non-invasive Vagus Nerve Stimulation (nVNS) on Cognitive Performance Caused by Sleep DeprivationGlobeNewsWire • 06/24/21
electroCore Announces Publication of Study on Non-Invasive Vagus Nerve Stimulation (nVNS) to Improve Clinical Outcomes and Molecular Biomarkers in Parkinson's Disease PatientsGlobeNewsWire • 06/02/21
electroCore, Inc. Celebrates Veterans and Active Members of the Military During National Military Appreciation MonthBusiness Wire • 05/20/21
electroCore Supports Results of Lancet Paper Highlighting the Benefits of Vagus Nerve Stimulation for Stroke PatientsBusiness Wire • 05/18/21
electroCore, Inc. (ECOR) CEO Dan Goldberger on Q1 2021 Results - Earnings Call TranscriptSeeking Alpha • 05/10/21
electroCore to Announce First Quarter 2021 Financial Results on Thursday, May 6GlobeNewsWire • 04/29/21
electroCore, Inc. Announces Johns Hopkins University School of Medicine Study of Non-Invasive Vagus Nerve Stimulation (nVNS) for Symptomatic Exacerbation of Nausea in Patients with Gastroparesis and Related DisordersGlobeNewsWire • 04/26/21
electroCore Announces Publication in Nature Reviews: Neurology Highlighting the Role of Non-Invasive Vagus Nerve Stimulation (nVNS) as an Emerging Treatment for Cluster HeadacheGlobeNewsWire • 04/15/21
electroCore Provides Business Update and Select First Quarter 2021 Financial GuidanceGlobeNewsWire • 04/13/21
ElectroCore's Stock Is Trading Higher As nVNS Decreases Certain COVID-19-Associated BiomarkersBenzinga • 04/08/21
electroCore Announces Top Line Results from SAVIOR-1 study of Non-Invasive Vagus Nerve Stimulation (nVNS) in Hospitalized COVID-19 PatientsGlobeNewsWire • 04/08/21